Targeting apoptotic pathways for cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Apoptosis, a form of programmed cell death, is crucial for cancer treatment.
• Dysregulation of apoptosis is a hallmark of cancer, driving tumor growth and therapy resistance.
• Apoptosis pathways intersect with critical signaling networks like p53 and the integrated stress response (ISR).

Purpose of the Study:

• To review promising anticancer therapies that induce apoptosis.
• To discuss novel drug targets, mechanisms of action, and resistance strategies.
• To highlight agents targeting BCL-2, TRAIL, DR5, p53, and ISR pathways.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of therapeutic strategies targeting cell death pathways.
• Examination of drug resistance mechanisms.

Main Results:

• Several therapeutic strategies are in development, including BCL-2 inhibitors, TRAIL analogues, and DR5 antibodies.
• Targeting p53 and ISR pathways offers new avenues for cancer treatment.
• Understanding resistance mechanisms is vital for optimizing therapy efficacy.

Conclusions:

• Targeting apoptosis and related pathways represents a significant frontier in oncology.
• Developing novel agents against BCL-2, TRAIL, DR5, p53, and ISR holds therapeutic promise.
• Further research into drug mechanisms and resistance is essential for advancing cancer care.